Hummingbird Ventures is a global early-stage venture capital fund with over $500M in assets under management, with a focus on investing in exceptional founders. Hummingbird works best with outsiders who challenge industry boundaries and conventions.

Tendai is an early stage biotech investor at Hummingbird Ventures. She completed her PhD at the University of Cambridge, engineering proteomic tools to study the dynamics of leptin signaling in the hypothalamus.

Early stage VC @hummingbirdvc

Currently investing at Hummingbird Ventures. Passionate about entrepreneurship, venture capital, and the outsized impact technology could have on emerging markets.